Loading...
Integra LifeSciences Holdings Corporation
IART•NASDAQ
Healthcare
Medical - Devices
$11.59
$-0.32(-2.69%)
Integra LifeSciences Holdings Corporation (IART) Financial Performance & Statements
Review Integra LifeSciences Holdings Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.47%
↑ 4.47%
Operating Income Growth
-74.53%
↓ 74.53%
Net Income Growth
-110.25%
↓ 110.25%
Operating Cash Flow Growth
-7.55%
↓ 7.55%
Operating Margin
2.91%
↑ 2.91%
Gross Margin
65.53%
↑ 65.53%
Net Profit Margin
-1.78%
↓ 1.78%
ROE
-2.52%
↓ 2.52%
ROIC
4.86%
↑ 4.86%
Integra LifeSciences Holdings Corporation (IART) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Integra LifeSciences Holdings Corporation stock.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Revenue | $1.61B | $1.54B | $1.56B | $1.54B |
| Cost of Revenue | $728.47M | $653.18M | $587.36M | $597.81M |
| Gross Profit | $882.06M | $888.39M | $970.31M | $944.64M |
| Gross Profit Ratio | $0.55 | $0.58 | $0.62 | $0.61 |
| R&D Expenses | $115.38M | $174.59M | $101.19M | $93.05M |
| SG&A Expenses | $716.98M | $592.64M | $616.32M | $637.45M |
| Operating Expenses | $853.65M | $836.39M | $731.39M | $747.41M |
| Total Costs & Expenses | $1.58B | $1.43B | $1.32B | $1.35B |
| Interest Income | $20.04M | $17.20M | $11.92M | $6.74M |
| Interest Expense | $70.63M | $51.38M | $49.59M | $50.40M |
| Depreciation & Amortization | $140.89M | $123.51M | $121.11M | $123.67M |
| EBITDA | $193.29M | $274.01M | $391.10M | $366.33M |
| EBITDA Ratio | $0.12 | $0.18 | $0.18 | $0.16 |
| Operating Income | $28.41M | $111.53M | $238.92M | $197.23M |
| Operating Income Ratio | $0.02 | $0.07 | $0.15 | $0.13 |
| Other Income/Expenses (Net) | -$46.65M | -$30.46M | -$25.03M | $17.45M |
| Income Before Tax | -$18.24M | $81.07M | $213.89M | $214.68M |
| Income Before Tax Ratio | -$0.01 | $0.05 | $0.14 | $0.14 |
| Income Tax Expense | -$11.29M | $13.33M | $33.34M | $45.60M |
| Net Income | -$6.94M | $67.74M | $180.55M | $169.07M |
| Net Income Ratio | -$0.004 | $0.04 | $0.12 | $0.11 |
| EPS | -$0.09 | $0.87 | $2.18 | $2.00 |
| Diluted EPS | -$0.09 | $0.84 | $2.16 | $1.98 |
| Weighted Avg Shares Outstanding | $77.01M | $78.17M | $83.00M | $84.70M |
| Weighted Avg Shares Outstanding (Diluted) | $77.01M | $80.34M | $83.52M | $85.48M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan